Need professional-grade analysis? Visit stockanalysis.com
$27.38B
N/A
852
N/A
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY59.06, down 3.26% from the previous close.
Over the past year, 688192 has traded between a low of CNY47.53 and a high of CNY85.21. The stock has gained 0.5% over this period. It is currently 30.7% below its 52-week high.
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A has a market capitalization of $27.38B.
Dizal (Jiangsu) Pharmaceutical Co., Ltd., a biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases. Its assets include the ZEGFROVY, for the treatment of solid tumors; Golidocitinib to treat hematological malignancy, solid tumors, and immunological diseases; Birelentinib indicated for hematological malignancy; DZD2269, DZD1516, and DZD6008 for solid tumors; and GW5282 for hematological malignancy and solid tumors. The company was founded in 2017 and is based in Shanghai, China.
Side-by-side comparison against top Healthcare peers.